Biotech Business Week articles from November 2004

Biotech Business Week archives from November 2004

p-tau 231 assay improves early stage Alzheimer disease detection.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- An assay developed by Applied NeuroSolutions (APNS), when combined with magnetic resonance imaging (MRI), was shown to identify neural signposts in patients with mild cognitive impairment (MCI), a...

JCAHO Sentinel Event Alert issued targeted at preventing anesthesia awareness.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Aspect Medical Systems (ASPM) announced that the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has issued a new Sentinel Event Alert (issue no. 32) aimed at preventing and...

PC cell-derived growth factor inflames breast tumor aggression.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- PC cell-derived growth factor inflames breast tumor aggression. According to recent research published in the journal Carcinogenesis, "metastasis is a multi-step process involved in the progression...

Biogen enters pharmacodiagnostic research collaboration.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Epigenomics, AG, (ECX), a molecular diagnostic company developing tests based on DNA methylation, announced that the company has entered into a research collaboration with Biogen Idec (BIIB) to identify...

Court dismisses Promega's case against Applied Biosystems and Roche.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Applied Biosystems (ABI), an Applera Corp. business, announced that the U.S. District Court in Alexandria, Virginia, has dismissed on multiple grounds a case filed by the Promega Corp. against Applied...

Analysis showed teriparatide reduced fracture risk independent of bone turnover.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Data presented at the 26th annual meeting of the American Society for Bone and Mineral Research (ASBMR) show that the ability of teriparatide to prevent fractures remained consistent regardless of...

FDA approves medical device to treat AAA.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Cook, Inc., a privately held medical-device manufacturer, announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation solution for abdominal aortic aneurysms...

Candela enters exclusive distribution agreement for China.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Candela Corp. (CLZR), a company focused on the development and commercialization of aesthetic laser systems, and Chindex International, Inc., (CHDX), an independent American provider of western...

New technique targets pesticide-resistant insects.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Australian and U.K. scientists have developed a technique to effectively control the "super pests" that are highly resistant to pesticides used on important food and fiber crops worldwide. The...

Biotechcompany scientist presented with award from Alzheimer Association.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Prana Biotechnology Limited (NASDAQ:PRAN)(NASDAQ:ASX:)(NASDAQ:PBT) announced that Dr. Ashley Ian Bush, cofounding scientist and senior scientific consultant to Prana Biotechnology, was named a 2004...

Forecast: Considerable research to be devoted to pathomechanism of Alzheimer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Management of Alzheimer disease remains a challenge, with nearly 8 million sufferers from this condition in the 7 major world markets and anticipated increases in the future. Considerable research...

Pharma company announces progress with Alzheimer strategy.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) has made steady progress pursuing a multipronged strategy against Alzheimer disease (AD) that targets the prevention, diagnosis and treatment of AD,...

Pharma company's long-term study of Celebrex expected to continue.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Pfizer Inc. said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to...

CytRx adds three drug candidates with acquisition of Biorex assets.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- CytRx Corp. (CYTR) has acquired all the clinical and pharmaceutical assets and related intellectual property of Hungary-based Biorex Research & Development, RT, (Biorex), a privately held biotechnology...

Phase I trial of Hematide initiated.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Affymax, Inc., announced that it has initiated a placebo controlled, phase I dose-finding clinical trial with its lead product candidate, Hematide, a peptide-based erythropoiesis stimulating agent (ESA)...

Company introduces low permeability AAA Device.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- W. L. Gore & Associates, Inc., a manufacturer of expanded polytetrafluoroethylene (ePTFE) vascular grafts and endovascular devices including the GORE EXCLUDER Bifurcated Endoprosthesis, announced...

Researchers begin evaluating efficacy of JuvImmune immunostimulant platform.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Juvaris BioTherapeutics, Inc., announced that researchers at the University of New Mexico have begun evaluating the efficacy of the JuvImmune immunostimulant platform against anthrax and small pox...

Biotech company working to address problem of antibiotic resistance.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- New biotechnology company, RiboNovix, Inc., is addressing the worsening problem of antibiotic-resistant bacteria by developing new anti-infectives that are less susceptible to drug resistance. Over...

Antisense inhibitors of TRADD could modulate TNF-related pathologies.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Antisense inhibitors of TRADD could modulate TNF-related pathologies. "Tumor necrosis factor (TNF) receptor 1-associated death domain protein (TRADD) is an adaptor protein known to be involved in...

FDA approves first U.S. implants of Philos II DR-T pacemaker.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Biotronik, Inc., announced U.S. Food and Drug Administration (FDA) approval and first implants of a second-generation Home Monitoring product: the Philos II DR-T pacemaker. The device is part of a...

Pharmaceutical company offers its alternative to recalled arthritis medication.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- With the recent recall of the arthritis medication rofecoxib, Boehringer Ingelheim announced that it is supporting patients while they look for new alternatives. The company offered up its own...

Research shows gelatine stimulates synthesis of type II collagen.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Collagen hydrolysate (CH), a special type of gelatine, was shown to stimulate synthesis of type II collagen in a study presented at the annual meeting of the American Society for Bone and Mineral...

Company addresses possible reimbursement for VentrAssist LVAS.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Ventracor, Ltd., (VCR), said there was evidence the cost of its artificial heart devices used in its pending U.S. clinical trials would be fully reimbursed and there was potential for reimbursement at...

Suite of asthma control and asthma impact surveys launched.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- QualityMetric Incorporated announced launch of a full suite of asthma control and asthma impact surveys for adults and children that measure health-related quality of life (HRQoL) from the patient...

Results presented on antibody-based treatment of atherosclerosis.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A new report describes the research performed by a research team lead by professor Jan Nilsson at the University Hospital MAS in Malmo in collaboration with BioInvent International AB (BINV) in Lund....

Allergy academy presents Samter Journalism Awards for health, medical reporting.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The American Academy of Allergy, Asthma and Immunology (AAAAI) announced the 5th Annual Samter Journalism Award Program. The AAAAI developed the Samter Award to celebrate and award outstanding...

Biotech firm lauds Nobel winner, announces olfactory-based government contract.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Joseph K. Pagano, chairman of the board of Sentigen Holding Corp. (SGHL), a biotechnology company, extended congratulations to Dr. Richard Axel, Sentigen's long term good friend and consultant, on being...

Genetics products company named to Technology Fast 50 Program for Washington.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) has been named to Deloitte's Technology Fast 50 Program for Washington State, a ranking of the 50 fastest growing technology companies in the area by Deloitte &...

Medical devices company ranks 30th on the Minnesota Technology Fast 50 program.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Synovis Life Technologies, Inc. (SYNO) placed 30th on Deloitte's Technology Fast 50 Program for Minnesota, a ranking of the 50 fastest-growing technology companies in the state. The Technology Fast...

Nanotechnology-based life sciences company's founder wins NIH award.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nanosphere Inc. announced that its founder, Chad A. Mirkin, PhD, has been selected as one of the first recipients of the U.S. National Institutes of Health (NIH) Director's Pioneer Award. The $2.5...

Nobel Prize awarded to researcher at cancer center.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Linda Buck, PhD, a member of Fred Hutchinson Cancer Research Center's Basic Sciences Division, was named winner of the 2004 Nobel Prize in physiology or medicine. She received the award for her...

Pharma company completes phase 1 clinical trial for complicated skin infections.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Peninsula Pharmaceuticals, Inc., announced that is has completed a phase 1 clinical trial for PPI-0903, one of its product candidates. Peninsula is investigating PPI-0903 as a potential treatment...

Avodart offers improvements in quality of life for men with prostate problems.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Men who suffer from benign prostatic hyperplasia (BPH) experience long-term benefits with the new treatment Avodart, according to a new study. For the first time, the study looked at the effects of...

Statistically significant positive phase II data reported on Cetrorelix.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- AEterna Zentaris, Inc., (AEZ; AEZS) announced statistically significant positive results from a randomized, double-blind, placebo-controlled phase II trial designed to evaluate different dosage regimens...

Peptidomics offers sensitive search for biomarkers.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The German biotech company BioVisioN opens up new possibilities for peptide biomarker research. Improvements of their proprietary Clinical Peptidomics technologies were presented at this year's...

Microarrays donated to Vanderbilt University.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A) and Vanderbilt University Medical Center (VUMC) announced that Agilent has donated cDNA microarray kits valued at $66,000 to the medical center. VUMC expects to use...

BioProcess International Conference & Exhibition unites 1,000 attendees.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The first-ever BioProcess International Conference & Exhibition in October united more than 1,000 attendees from worldwide biotech and pharmaceutical companies at the Boston Convention & Exhibition...

More than 1 million Bioanalyzer chips sold.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A) announced that it has sold more than one million LabChip chips - small, analytical devices used with the Agilent 2100 bioanalyzer to perform fast, automated analysis of...

Biotech company representative testified about proposal for BioShield II.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) announced that Alan P. Timmins, AVI's president and COO, testified in a joint hearing before the U.S. Senate Committee on Health, Education, Labor and Pensions and the U.S....

District of Columbia EHMSA licenses VisualDx diagnostic software.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Logical Images, a developer of point-of-care medical-diagnostic software, announced that VisualDx will support clinicians at 10 District of Columbia hospital emergency departments and 20 District of...

Gen-Probe signs licensing agreements.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Gen-Probe (GPRO) has signed nonexclusive licensing agreements with bioMerieux and its affiliates that provide bioMerieux options to access Gen-Probe's ribosomal RNA technologies for certain uses, and...

Chiron announces blood-screening licensing agreement.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) has granted a nonexclusive license to the blood transfusion centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and...

Swiss research tracks down the scent of sweat.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The sense of smell plays an important role in interpersonal relations. The human armpit contains chemical substances that - at least in premodern times - probably provided direction for the selection of...

Brain metastases patients' radiographic response at 3 months predicts survival.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- For brain metastases patients undergoing whole brain radiation therapy (WBRT), radiographic response in the brain at 3 months is a statistically significant predictor of prolonged survival, according to...

New findings from EFAPROXYN brain metastases trial releases.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (NASDAQ:ALTH) announced the presentation of new findings from its phase 3 clinical trial of the investigational radiation sensitizer EFAPROXYN (efaproxiral) in patients with...

Positive cancer data on ECO-4601 presented at symposium.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Ecopia BioSciences, Inc., (EIA) presented data on ECO-4601 in a poster entitled "A new antitumor compound, ECO-4601: Preclinical evaluation and in vivo efficacy in glioma" at the European Organization...

Analysis: New York City women continue to receive fewer mammograms.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Women in New York City continue to receive mammograms at much lower levels than those outside the downstate region, while Kings County (Brooklyn) still has the lowest county-specific mammography rate,...

China's FDA approves laser breast imaging device.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Imaging Diagnostic Systems, Inc., (IMDS) announced that its CT Laser Mammography system (CTLM) has received Chinese State Food and Drug Administration (SFDA) marketing approval. Following extensive...

Medical device company announces kit for accelerated partial breast irradiation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nucletron B.V. announced the release of OncoSystem Breast, a complete turnkey kit for accelerated partial breast irradiation (APBI). OncoSystem Breast is a compilation of Nucletron products and...

Medical technology company receives financing to introduce BreastScanIR.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Infrared Sciences Corporation (ISC) announced that it has completed a $1 million series A preferred stock financing, acquiring the capital necessary to introduce BreastScan IR to a broader market of...

NYU Medical Center begins validation study on early detection breast cancer test.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Power3 Medical Products, Inc. (OTCBB: PWRM) announced institutional review board (IRB) approval from New York University Medical Center to begin the clinical validation studies on the company's NAF Test...

Plus-size retailer raises funds to fight breast cancer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Catherines, a leading plus-size retailer with more than 450 stores nationwide, is proud to introduce a Breast Cancer Awareness pin to help raise money towards the fight against breast cancer. The...

Study links low HDL levels with increased risk of postmenopausal breast cancer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The 2004 update from the American Heart Association's (AHA) Heart Disease and Stroke Statistics, coupled with a recently published study, documents that more than 50 million American women have...

Biomedical foods company receives large order for Asorbine Flex+.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- NutraCea (BULLETIN BOARD: NTRZ) announced that they have received the largest purchase order this year for $240,000 and the second in 2 months from W.F. Young Co. for their Absorbine Flex+ formulation,...

Biotechnology company delists from TSX Venture Exchange.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Oragenics, Inc., (AMEX:ONI) (TSX VENTURE:ORA.U) announced that the company will delist from the TSX Venture Exchange and trade exclusively on the American Stock Exchange (AMEX) under the symbol "ONI."...

Biotechnology company files registration statement with SEC.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Integrated Pharmaceuticals, Inc, has filed a Form 10SB registration statement with the U.S. Securities Exchange Commission (SEC). The statement is now available on the SEC's EDGAR web site; it has...

Ernst & Young, LLP, resigns from audit of device company.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Vascular Solutions, Inc., (VASC) announced that Ernst & Young, LLP, has resigned as independent auditor of Vascular Solutions, Inc., due solely to Ernst & Young's stated lack of available personnel to...

GOLD'n GRO sales up 103% in first 9 months of 2004, third quarter sales up 194%.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Itronics Inc. (ITRO) reported that GOLD'n GRO sales by its subsidiary, Itronics Metallurgical, Inc., for the first 9 months of 2004 totaled approximately $858,000, a 103% increase over the prior year's...

Managed care company announced credit facility with GMAC-RFC Health Capital.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Prospect Medical Holdings, Inc., (PMHX.PK) (Prospect Medical) announced that it has entered into a $15 million credit facility with GMAC-RFC Health Capital. The facility is composed of a 3-year, $10...

Medical technology company announces results of shareholder audit.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- NanoSignal Corp. (Pink Sheets: NNOS) has determined, after an extensive review of a detailed shareholder audit, conclusive and stunning documented proof of the market making activity involving the...

Pharmaceutical company files universal shelf registration statement.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Company Inc. (Nastech) (NASDAQ:NSTK) announced that it has filed a universal shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC),...

Radiation therapy services management company added to Russell Indexes.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Radiation Therapy Services, Inc., (NASDAQ:RTSX) announced that it has been added to the Russell 3000 and Russell 2000 Indexes. Dr. Daniel Dosoretz, president and chief executive officer, stated,...

U.S. biotech invests in Australian cancer-focused company to widen collaboration.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- New York based biotechnology company Bioaccelerate, Inc. will invest in Australian Cancer Technology (ACU) by taking a $1.88 million share placement in the company. Included in the agreement is a...

Weight management products company announces updated financial guidance.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- NutriSystem, Inc., (AMEX:NSI) announced that based on preliminary results, it anticipates improved performance in the third quarter ended September 30, 2004, as compared to guidance originally provided...

Agilent Technologies to partner in bioinformatics work on $11.7M ATP grant.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Icoria, Inc., (ICOR) announced that Agilent Technologies has been approved by the U.S. National Institute of Standards and Technology (NIST) Advanced Technology Program (ATP) to partner with Icoria in...

Agreement signed for distribution of bacterial detection system in Japan.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Pall Corporation (NYSE:PLL) announced that it has finalized an agreement for Kawasumi Laboratories, Inc., to become the exclusive provider of the Pall eBDS (enhanced Bacterial Detection System) in...

Ambulatory care company announces mergers, financials, name change at meeting.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- SurgiCare Inc. (SRG), a Houston, Texas-based ambulatory surgery company, held its special meeting in lieu of an annual meeting of stockholders at its corporate headquarters in Houston. At the...

Amgen awards 3-year outsourced clinical study support project.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- IT&E International Group (ITER) announced the award of a 3-year, fully outsourced clinical study support project from Amgen, Inc. (AMGN). IT&E was chosen by Amgen to support statistical and clinical...

Biotech company undertakes value-enhancement plan.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Andromed, Inc., (AD) reported a value enhancement and restructuring plan aimed at rapidly raising Andromed's technological and strategic value with a view to a transaction leading to the merger or the...

Biotech firm strengthens drug pipeline by acquiring a phase II compound.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Biofrontera AG announced that it has acquired from ASAT AG, Zug, Switzerland, all intellectual property, know-how and material related to a phase II compound for the treatment of various cancerous and...

Cardiology instrument designer and manufacturer added to Russell Indices.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Stereotaxis, Inc. (STXS) announced that it has been added to the Russell 3000 and Russell 2000 Indices, as of October 1, 2004. "As a company that has recently completed an initial public offering,...

Chemistry-focused software developer expands facilities, names division heads.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Synthematix, Inc., a provider of chemistry reaction planning and knowledge management systems, has expanded its office space and added several employees in response to an expanding customer base and...

Clinical development organization forms centralized document and data centers.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- PRA International (PRA) announced the formation of centralized Document and Data Management Centers. The centers will serve as a single repository for all documents generated during PRA's clinical...

Clinical reference laboratory awarded Novation contract for testing services.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Specialty Laboratories, Inc. (SP), a hospital-focused clinical reference laboratory, has signed a supplier agreement with Novation, the supply company of VHA Inc. and the University HealthSystem...

Company changes name and prepares for HIV vaccine trial.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Research company Merix Bioscience announced the change of its name to Argos Therapeutics, Inc. Additionally, the company stated that it is preparing for an HIV clinical trial with Argos' proprietary...

Contract research organization opens office in top German biotech region.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- INC Research has opened an office in Germany, in Dusseldorf's Life Science Center. INC Research strategically located its facility in the North Rhine-Westphalia region of Germany, to be in close...

DNAPrint genomics to acquire majority ownership in German pharmaceutical company.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- DNAPrint genomics, Inc., (DNAP) has agreed to acquire a 51.77% stake in German pharmaceutical company Biofrontera, AG. DNAPrint simultaneously announced that it has received a commitment from...

Drug-testing company expands operations with move to new facilities.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Cozart, plc, announced their move to new premises on the Milton Park estate in Abingdon, Oxford, U.K. Cozart is a medical-diagnostics company which provides immunodiagnostic tests, particularly...

Information solutions company signs multiyear agreement with Boots the Chemist.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- IMS Health (RX) announced a multiyear agreement with Boots The Chemist to deliver more comprehensive, over-the-counter (OTC) healthcare intelligence on the U.K. marketplace. Under the agreement,...

Medical monitoring service changes stock symbol.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Medeorex, Inc., (MRXI) announced that it has completed a change in its stock trading symbol on the NASD Over-The-Counter Bulletin Board to "MRXI" from "CXTX." The company previously changed its...

Online science supplier expanding operations.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Online science supplier LabX announced a staff increase and expanded operations that will accommodate the accelerated growth of their online equipment marketplace. The company said that it is added...

Orthopedic products company presented technology overview at conference.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- ReGen Biologics, Inc., (OTC:RGBI) announced that Gerald E. Bisbee, Jr., PhD, chairman and chief executive officer of ReGen Biologics, will presented an overview of the company's technology and business...

Pharma company and IVAX conclude license agreement for anticancer agent.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nippon Shinyaku Co., Ltd., and IVAX Corporation concluded a license agreement for a novel anticancer agent, HMN-214. Under the agreement, Nippon Shinyaku has granted IVAX an exclusive license in...

Pharma company announced grant to Health Partners International of Canada.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Paladin Labs Inc. (TSX: PLB) announced that it has donated more than $400,000 in medication to Health Partners International of Canada (HPIC). This is vital support for HPIC's mission of improving...